Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group

MLA

J J, Bolger, et al. “Strontium-89 (Metastron) versus External Beam Radiotherapy in Patients with Painful Bone Metastases Secondary to Prostatic Cancer: Preliminary Report of a Multicenter Trial. UK Metastron Investigators Group.” Seminars in Oncology, vol. 20, no. 3 Suppl 2, June 1993. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........1c24a8b7a40e4a5d9ab775a6ea1e08b2&authtype=sso&custid=ns315887.

APA

J J, B., D P, D., D, K., V J, L., M D, M., P M, Q., N S, R., J M, R., & J, Y. (1993). Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group. Seminars in Oncology, 20(3 Suppl 2).

Chicago

J J, Bolger, Dearnaley D P, Kirk D, Lewington V J, Mason M D, Quilty P M, Reed N S, Russell J M, and Yardley J. 1993. “Strontium-89 (Metastron) versus External Beam Radiotherapy in Patients with Painful Bone Metastases Secondary to Prostatic Cancer: Preliminary Report of a Multicenter Trial. UK Metastron Investigators Group.” Seminars in Oncology 20 (3 Suppl 2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........1c24a8b7a40e4a5d9ab775a6ea1e08b2&authtype=sso&custid=ns315887.